Abstract
Purpose of Review: Small non-coding RNAs regulate gene expression and are highly implicated in heart failure. Recently, an additional level of post-transcriptional regulation has been identified, referred to as the epitranscriptome, which encompasses the body of post-transcriptional modifications that are placed on RNA molecules. In this review, we summarize the current knowledge on the small non-coding RNA epitranscriptome in heart failure. Recent Findings: With the rise of new methods to study RNA modifications, epitranscriptome research has begun to take flight. Over the past 3 years, the number of publications on the epitranscriptome in heart failure has significantly increased, and we expect many more highly relevant publications to come out over the next few years. Summary: Currently, at least six modifications on small non-coding RNAs have been investigated in heart failure-relevant studies, namely N6-adenosine, N5-cytosine and N7-guanosine methylation, 2’-O-ribose-methylation, adenosine-to-inosine editing, and isomiRs. Their potential role in heart failure is discussed.
| Original language | English |
|---|---|
| Journal | Current Heart Failure Reports |
| Volume | 19 |
| Issue number | 5 |
| Pages (from-to) | 255-266 |
| Number of pages | 12 |
| ISSN | 1546-9530 |
| DOIs | |
| Publication status | Published - Oct 2022 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022, The Author(s).
Keywords
- Chemical modifications
- Epitranscriptome
- Heart failure
- Post-transcriptional regulation
- Small noncoding RNAs
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS